These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9843660)

  • 1. The use of nested RT-PCR of prostate-specific membrane antigen in blood cells: implications for the detection of haematogenous neoplastic cells in patients with prostate adenocarcinoma.
    Lucotte G; Mercier G; Burckel A
    Mol Cell Probes; 1998 Dec; 12(6):421-5. PubMed ID: 9843660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2.
    Kawakami M; Okaneya T; Furihata K; Nishizawa O; Katsuyama T
    Cancer Res; 1997 Oct; 57(19):4167-70. PubMed ID: 9331068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
    Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
    Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
    Shariat SF; Kattan MW; Song W; Bernard D; Gottenger E; Wheeler TM; Slawin KM
    Cancer Res; 2003 Sep; 63(18):5874-8. PubMed ID: 14522912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells.
    McIntyre IG; Spreckley K; Clarke RB; Anderson E; Clarke NW; George NJ
    Br J Cancer; 2000 Oct; 83(8):992-7. PubMed ID: 10993644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer.
    Patel K; Whelan PJ; Prescott S; Brownhill SC; Johnston CF; Selby PJ; Burchill SA
    Clin Cancer Res; 2004 Nov; 10(22):7511-9. PubMed ID: 15569981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of urine DD3/PSA mRNA ratio by duplex TaqMan RT-PCR assay and evolution of its primary application].
    Chen FP; Chen LL; Shen M; Chen W; Tao ZH; Wu XL; Hu YP; Li CD; Chen ZG; Chen XD
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):261-4. PubMed ID: 18361839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
    Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee KH
    Int J Urol; 2007 Jul; 14(7):635-43. PubMed ID: 17645609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction.
    Noguchi M; Miyajima J; Itoh K; Noda S
    Int J Urol; 1997 Jul; 4(4):374-9. PubMed ID: 9256327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
    Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
    J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence.
    Mejean A; Vona G; Nalpas B; Damotte D; Brousse N; Chretien Y; Dufour B; Lacour B; Bréchot C; Paterlini-Bréchot P
    J Urol; 2000 Jun; 163(6):2022-9. PubMed ID: 10799250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative real-time RT-PCR assay for PCA3.
    Väänänen RM; Rissanen M; Kauko O; Junnila S; Väisänen V; Nurmi J; Alanen K; Nurmi M; Pettersson K
    Clin Biochem; 2008 Jan; 41(1-2):103-8. PubMed ID: 17996198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
    Llanes L; Ferruelo A; Luján M; Pascual C; García-Mediero JM; Berenguer A
    Prostate Cancer Prostatic Dis; 2005; 8(3):248-52. PubMed ID: 15897916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
    Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
    Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.